News | March 10, 2026
Hopewell Therapeutics sublicenses breakthrough LNP technology to Foxcroft for cancer vaccine development
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Advancing toward Phase 2a evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track designation
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Agency initiates safety label change and notifies physicians of possible link
Subscribe To Our Newsletter & Stay Updated
